Catalyst Wire Dossier Catalyst Wire Dossier

iSCLife®-ACI

mesenchymal stem cells · Sclnow Biotechnology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iSCLife®-ACI, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction [Phase 1]

See pricing